Skip to main content

 News

Christmas market at the Institute

Christmas market at the Jules Bordet Institute from Monday 11 to Friday 15/12/2017 from 10h to 17h30 Come and discover our gift ideas for the end of year celebrations !!! All the profits will be donated to the Friends of the Jules Bordet Institute who actively support research at the Institute and the Nurses Fund for the well-being of patients! Address: bd Waterloo 121, 1000 Brussels
(read more)

MyPEBS study - For a personalised cancer screening

Press release (25/10/2017) MyPEBS Study (My Personal Breast Screening)
For a personalised cancer screening Brussels, 25 October 2017 - The Jules Bordet Institute, an integrated centre in the fight against
cancer and a reference in Belgium and abroad, is participating in a study with the potential to
modify the breast cancer screening programme. The importance of screening for breast cancer is now beyond question, but are…
(read more)

Détresses et résiliences après un cancer du poumon

Communiqué de presse (25/10/2017) Détresses et résiliences après un cancer du poumon Symposium à l’occasion du 10ème anniversaire de VAINCRE, comité de soutien des patients de l’ELCWP Samedi 18 novembre 2017 de 14h -16h30
Auditorium Tagnon - Institut Jules Bordet - Boulevard de Waterloo 121 - 1000 Bruxelles À l’occasion du 10ème anniversaire de l’association de patients « Vaincre », l’Institut Jules Bordet
organise un…
(read more)

New website of the Institut Jules Bordet

Press release (21/09/2017) 

The brand new website of the Jules Bordet Institute is now online! www.bordet.be
  Brussels, 21 September 2017 – The Jules Bordet Institute, an integrated centre in the fight against cancer and a reference in Belgium and abroad, is placing online its brand new website and is proud to announce its launch this Thursday 21 September. Home Page of the new website of the Institut…
(read more)

Viral leukemia, monitor therapeutic response

Press release (05/09/2017) Novel tool to monitor therapeutic response of patients with viral leukemia
  Brussels, 5 September 2017 – A few months after the discovery of a novel mechanism by which viruses cause leukemia (Nature Communications, 23rd May 2017), the research team led by Anne Van den Broeke (Institut Jules Bordet - University of Brussels and GIGAUniversity of Liège) publishes a new study that addresses a clinical question…
(read more)

Viva -  Gala for the profit of the "Amis"  

13/11/2017  : Viva -  Gala for the profit of the "Amis"   Wolubilis - 20h15 Concert-spectacle around Vivaldi Original idea of Vincent Engel With Pietro Pizzuti (Vivaldi), the singers Julia Szproch and Sarah Théry, of the Queen Elisabeth Music Chapel, and the baroque ensemble Les Muffatti. Info and reservations: 02/541 34 11
(read more)

Renovation work on the Porte de Hal tunnel

Renovation work on the Porte de Hal tunnel is necessary. They will be carried out in 6 phases and will be completed by the beginning of 2019. In order to limit disturbances the tunnel will remain open as far as possible. CURRENTLY : we are in phase 4 of the work : Free left bands during the day. More information : click here To be informed
• send you email to mobilite@sprb.brussels
• consult alternatives :
- SNCB :…
(read more)

Viruses cause leukemia

Press release (23/05/2017) Viruses hijack cancer genes to cause leukemia
  Brussels, 23 May 2017 – A team of researchers led by Anne Van den Broeke (Institut Jules Bordet - University of Brussels and GIGA-University of Liège) has uncovered a novel mechanism by which viruses cause leukemia. These new findings, published on 23rd May in Nature Communications, could be key to the understanding of virus…
(read more)

Metastatic breast cancers

Press release (24/04/2017) Metastatic breast cancers - Characterising the profile of metastases for improved treatment
  Brussels, 24 April 2017 – Researchers at the Jules Bordet Institute - Université libre de Bruxelles, VIB and KU Leuven published this 21 of April an important study offering a better understanding of the progression of breast cancer. The conclusions could have an impact on care for patients…
(read more)